These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1845175)

  • 1. Testing for germ line p53 mutations in cancer families.
    Li FP; Correa P; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):91-4. PubMed ID: 1845175
    [No Abstract]   [Full Text] [Related]  

  • 2. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
    Frebourg T; Barbier N; Yan YX; Garber JE; Dreyfus M; Fraumeni J; Li FP; Friend SH
    Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
    Evans DG; Birch JM; Thorneycroft M; McGown G; Lalloo F; Varley JM
    J Med Genet; 2002 Dec; 39(12):941-4. PubMed ID: 12471212
    [No Abstract]   [Full Text] [Related]  

  • 7. Li-Fraumeni syndrome.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():275-86. PubMed ID: 7863100
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.
    Birch JM
    Br J Cancer; 1992 Sep; 66(3):424-6. PubMed ID: 1520579
    [No Abstract]   [Full Text] [Related]  

  • 9. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
    Wu CC; Shete S; Amos CI; Strong LC
    Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic TP53 variants frequently confound germ-line testing results.
    Weitzel JN; Chao EC; Nehoray B; Van Tongeren LR; LaDuca H; Blazer KR; Slavin T; Facmg DABMD; Pesaran T; Rybak C; Solomon I; Niell-Swiller M; Dolinsky JS; Castillo D; Elliott A; Gau CL; Speare V; Jasperson K
    Genet Med; 2018 Aug; 20(8):809-816. PubMed ID: 29189820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Li-Fraumeni syndrome].
    Tsunematsu Y
    Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel p53 germline mutation in a patient with Li-Fraumeni syndrome.
    Wong SS; Lozano G; Gaff CL; Gardner RJ; Strong LC; Aittomäki K; Lindeman GJ
    Intern Med J; 2003 Dec; 33(12):621. PubMed ID: 14656244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Li-Fraumeni syndrome].
    Tokunaga A; Onda M; Matsukura N; Kato S
    Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method for detection of germinal mutations in the p53 tumor suppressor gene].
    Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P
    Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T; Soussi T
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
    Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J
    Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.